Immuneering Corp (IMRX)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Benjamin J. Zeskind
Employees:
60
245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MA 02142
617-500-8080

Immuneering Corporation focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer.

Data derived from most recent annual or quarterly report
Market Cap 173.397 Million Shares Outstanding26.392 Million Avg 30-day Volume 39.768 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-1.61
Price to Revenue746.8446 Debt to Equity0.0 EBITDA-48.171 Million
Price to Book Value3.1008 Operating Margin-9657.5331 Enterprise Value260.772 Million
Current Ratio16.542 EPS Growth0 Quick Ratio16.162
1 Yr BETA 1.1803 52-week High/Low 24.75 / 3.74 Profit Margin-9494.8637
Operating Cash Flow Growth-53.6731 Altman Z-Score18.0168 Free Cash Flow to Firm 0

Are you looking for this stock instead?

View SEC Filings from IMRX instead.

View recent insider trading info

Funds Holding IMRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding IMRX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-11-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K/A: filed on 2022-09-19:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-08-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-25:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    NEUFELD LEAH R CHIEF PEOPLE OFFICER

    88,600 2022-10-31 2

    MORALES MALLORY VICE PRESIDENT, FINANCE

    2,434 2022-08-11 2

    CARPENTER ROBERT J

    14,200 2022-06-21 1

    BERMAN ANN E

    14,200 2022-06-21 2

    HAUSMAN DIANA

    6,185 2022-06-21 3

    KEATING LAURIE

    14,200 2022-06-21 2

    FEINBERG PETER

    14,200 2022-06-21 2

    HALL BRETT MATTHEW CHIEF SCIENTIFIC OFFICER

    332,685 2022-05-25 4

    BOOKMAN MICHAEL GENERAL COUNSEL AND SECRETARY

    2,402 2022-05-17 2

    AMIN BIREN CFO, TREASURER

    7,898 2022-05-12 2

    ZESKIND BENJAMIN J. PRESIDENT AND CEO

    3,360,279 2022-04-12 5

    BARRETT SCOTT CHIEF MEDICAL OFFICER

    7,563 2022-03-22 2

    CORMORANT ASSET MANAGEMENT, LP

    CHEN BIHUA

    CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

    CORMORANT PRIVATE HEALTHCARE FUND III LP

    • 10% Owner
    • FORMER 10% OWNER
    3,955,256 2021-08-03 0

    SCOTTI DONALD JAMES PRESIDENT

    • Officer
    • Director
    • 10% Owner
    27,850,247 2010-05-28 0

    TAKATS JOSEPH RICHARD SENIOR EXEC. VP (MARKETING)

    • Officer
    • Director
    • 10% Owner
    27,850,247 2010-05-28 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    NEUFELD LEAH R CHIEF PEOPLE OFFICER

    2022-11-02 09:03:28 -0400 2022-10-31 A 88,600 a 88,600 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    IMMUNEERING CORP - CLASS A IMRX 2022-11-25 22:15:03 UTC -2.8631 6.6831 100000
    IMMUNEERING CORP - CLASS A IMRX 2022-11-25 21:45:04 UTC -2.8631 6.6831 100000
    IMMUNEERING CORP - CLASS A IMRX 2022-11-25 21:15:03 UTC -2.8631 6.6831 100000
    IMMUNEERING CORP - CLASS A IMRX 2022-11-25 20:45:03 UTC -2.7175 6.5375 100000
    IMMUNEERING CORP - CLASS A IMRX 2022-11-25 20:15:03 UTC -2.7175 6.5375 100000
    IMMUNEERING CORP - CLASS A IMRX 2022-11-25 19:45:04 UTC -2.7175 6.5375 100000
    IMMUNEERING CORP - CLASS A IMRX 2022-11-25 19:15:03 UTC -2.7175 6.5375 100000
    IMMUNEERING CORP - CLASS A IMRX 2022-11-25 18:45:03 UTC -2.7175 6.5375 100000
    IMMUNEERING CORP - CLASS A IMRX 2022-11-25 18:15:03 UTC -2.7175 6.5375 100000
    IMMUNEERING CORP - CLASS A IMRX 2022-11-25 17:45:04 UTC -2.7175 6.5375 100000
    IMMUNEERING CORP - CLASS A IMRX 2022-11-25 17:15:03 UTC -2.7175 6.5375 100000
    IMMUNEERING CORP - CLASS A IMRX 2022-11-25 16:45:04 UTC -2.7175 6.5375 100000
    IMMUNEERING CORP - CLASS A IMRX 2022-11-25 16:15:03 UTC -2.7175 6.5375 100000
    IMMUNEERING CORP - CLASS A IMRX 2022-11-25 15:45:03 UTC -2.7175 6.5375 100000
    IMMUNEERING CORP - CLASS A IMRX 2022-11-25 15:15:03 UTC -2.7175 6.5375 100000
    IMMUNEERING CORP - CLASS A IMRX 2022-11-25 14:45:04 UTC -2.7175 6.5375 100000
    IMMUNEERING CORP - CLASS A IMRX 2022-11-25 14:15:04 UTC -2.7175 6.5375 100000
    IMMUNEERING CORP - CLASS A IMRX 2022-11-25 13:45:03 UTC -2.3633 6.1833 100000
    IMMUNEERING CORP - CLASS A IMRX 2022-11-25 13:15:03 UTC -2.3633 6.1833 100000
    IMMUNEERING CORP - CLASS A IMRX 2022-11-25 12:45:03 UTC -2.3633 6.1833 100000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Weiss Strategic Interval Fund- Weiss Strategic Interval Fund IMRX -1575.0 shares, $-8520.75 2022-06-30 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments